No. 22-319

Saloojas, Inc. v. Aetna Health of California, Inc.

Lower Court: Ninth Circuit
Docketed: 2022-10-05
Status: Denied
Type: Paid
Response Waived
Tags: cares-act congressional-intent diagnostic-testing healthcare-reimbursement private-remedy private-right-of-action reimbursement statutory-interpretation
Key Terms:
ERISA SocialSecurity Securities JusticiabilityDoctri
Latest Conference: 2022-11-18
Question Presented (AI Summary)

Did Congress have an implicit intent to create a private remedy in favor of diagnostic testing providers for full reimbursement under the CARES Act?

Question Presented (OCR Extract)

QUESTION PRESENTED Did Congress have an implicit intent to create a private remedy in favor of diagnostic testing providers for full reimbursement under the CARES Act? i II.

Docket Entries

2022-11-21
Petition DENIED.
2022-11-02
DISTRIBUTED for Conference of 11/18/2022.
2022-10-26
Waiver of right of respondent Aetna Health of California, Inc. to respond filed.
Main DocumentMain Document
2022-10-03
Petition for a writ of certiorari before judgment filed. (Response due November 4, 2022)
PetitionProof of ServiceCertificate of Word CountPetitionProof of ServiceCertificate of Word Count

Attorneys

Aetna Health of California, Inc.
Emily Seymour Costin — Alston & Bird, LLP, Respondent
Saloojas, Inc.
Michael Lynn Gabriel — Law Office of Michael Lynn Gabriel, Petitioner